SEER实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	232 183
平均成交量	528 593
市值	145.09M
EPS	$0 ( 2024-02-29 )
下一个收益日期	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.660
ATR14	$0.00300 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-07	Farokhzad Omid	Sell	52 857	Class A Common Stock
2024-02-06	Kogan Elona	Buy	123 153	Class A Common Stock
2024-02-22	Kogan Elona	Sell	12 684	Class A Common Stock
2024-02-06	Kogan Elona	Buy	140 000	Employee Stock Option (right to buy)
2024-02-06	Kogan Elona	Buy	79 729	Employee Stock Option (right to buy)

INSIDER POWER
86.12
Last 98 transactions
Buy: 6 813 760 \| Sell: 922 350

音量相关性

長: 0.29 (neutral)

短: 0.91 (very strong)

Signal:(68.252) Expect same movement, but be aware

Seer, Inc. 相关性

10 最正相关
GXGX	0.92
CRON	0.911
NVTSW	0.908
IRBT	0.908
EVLO	0.906
CREG	0.903
SWAV	0.902
EPSN	0.899
HOL	0.898
BCAB	0.897

10 最负相关
BRIV	-0.911
PATK	-0.908
ALXN	-0.907
APMI	-0.906
GMFI	-0.905
ENTF	-0.905
CBRG	-0.904
ACAB	-0.903
ENER	-0.903
EMLD	-0.903

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Seer, Inc. 相关性 - 货币/商品

-0.69
( moderate negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.58
( weak negative )

0.50
( neutral )

Seer, Inc. 财务报表

Annual	2023
营收:	$15.18M
毛利润:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2023
营收:	$15.18M
毛利润:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2022
营收:	$14.69M
毛利润:	$6.74M (45.91 %)
EPS:	$-1.420

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.164

Financial Reports:

No articles found.

Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

实时更新： Seer, Inc. [SEER]

Upcoming Earnings Alert